Patients $18 years of age were eligible
to participate if they had type 2 diabetes
for a duration of $3 months and #5
years, glycosylated hemoglobin A1c
(HbA1c) $6.5% ($48 mmol/mol) and
#9.5% (# 80 mmol/mol), were on diet
and exercise alone, or on one oral antihyperglycemic
medication (OAM) for
$3 months prior to screening. Individuals
who were receiving an OAM were
only eligible if they were taking #50%
of the approved maximum daily dose
per respective labels in participating
countries.